Sujata Sharma

Title: Sujata Sharma: Innovator in PCSK9 Antagonists

Introduction

Sujata Sharma is a prominent inventor based in Eagleville, PA (US). She has made significant contributions to the field of biochemistry, particularly in the development of PCSK9 antagonists. Her work is crucial for advancing treatments for conditions associated with PCSK9 activity.

Latest Patents

Sujata Sharma holds a patent for AX132 PCSK9 antagonists. This invention discloses antagonists of human proprotein convertase subtilisin-kexin type 9 (PCSK9). The disclosed antagonists are effective in inhibiting PCSK9 function, making them desirable for treating conditions linked to PCSK9 activity. The patent also includes nucleic acid encoding for these antagonists, vectors, host cells, and compositions comprising the antagonists. Additionally, methods for creating PCSK9-specific antagonists and their applications for inhibiting or antagonizing PCSK9 function are detailed in the patent.

Career Highlights

Sujata Sharma is currently employed at Merck Sharp & Dohme Corp., where she continues her innovative work in biochemistry. Her research has the potential to impact the treatment of various health conditions significantly.

Collaborations

Sujata has collaborated with notable colleagues, including Peter Peizhi Luo and Kevin Caili Wang. Their combined expertise enhances the research and development of effective treatments in their field.

Conclusion

Sujata Sharma's contributions to the development of PCSK9 antagonists represent a significant advancement in medical science. Her innovative work at Merck Sharp & Dohme Corp. continues to pave the way for new therapeutic options.